733748-92-0 Usage
Uses
Used in Pharmaceutical Research:
4-(3-Isopropyl-1,2,4-oxadiazol-5-yl)piperidine is used as a research compound for its potential as a central nervous system stimulant, which may be beneficial in the development of treatments for various neurological disorders.
Used in Organic Synthesis:
In the field of organic synthesis, 4-(3-Isopropyl-1,2,4-oxadiazol-5-yl)piperidine is used as a building block or intermediate. Its unique structure allows it to be incorporated into the synthesis of a variety of organic compounds, contributing to the creation of new molecules with potential applications in various industries.
Used in Medicinal Chemistry:
4-(3-Isopropyl-1,2,4-oxadiazol-5-yl)piperidine is utilized in medicinal chemistry as a key intermediate in the development of new drugs. Its properties make it a valuable component in the design and synthesis of pharmaceuticals intended to address a range of health conditions, particularly those related to the nervous system.
Used in Drug Development:
4-(3-ISOPROPYL-1,2,4-OXADIAZOL-5-YL)PIPERIDINE is also used in drug development as a precursor in the synthesis of potential therapeutic agents. Its role in creating new pharmaceuticals highlights its importance in advancing treatments for neurological and other disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 733748-92-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,3,3,7,4 and 8 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 733748-92:
(8*7)+(7*3)+(6*3)+(5*7)+(4*4)+(3*8)+(2*9)+(1*2)=190
190 % 10 = 0
So 733748-92-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H17N3O/c1-7(2)9-12-10(14-13-9)8-3-5-11-6-4-8/h7-8,11H,3-6H2,1-2H3
733748-92-0Relevant academic research and scientific papers
NOVEL TRIAZOLONE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
-
, (2014/11/13)
The present invention provides a triazolone derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The triazolone derivative or its pharmaceutically acceptable salt can effectively activate GPR119; and therefore be usefully applied for preventing or treating diabetes mellitus.
NEW BICYCLIC COMPOUND FOR MODULATING G PROTEIN-COUPLED RECEPTORS
-
Paragraph 0228-0230, (2013/10/22)
The present invention relates to a bicyclic compound for modulating G protein-coupled receptors. The inventive compound provides preventing or treating a disease associated with the modulation of G protein-coupled receptors, particularly GPR119 G protein-coupled receptors.
NEW BICYCLIC COMPOUND FOR MODULATING G PROTEIN-COUPLED RECEPTORS
-
Page/Page column 33, (2012/07/27)
The present invention relates to a bicyclic compound for modulating G protein-coupled receptors. The inventive compound provides preventing or treating a disease associated with the modulation of G protein-coupled receptors, particularly GPR119 G protein-coupled receptors.
